The relationship between ADAM17 promoter polymorphisms and sporadic Alzheimer's disease in a Northern Chinese Han population

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Min WangJianping Jia

Abstract

The deposition of amyloid beta peptides (Abeta) in the brain is crucial in the pathogenesis of Alzheimer's disease (AD). A disintegrin and metalloproteinase (ADAM) 17 cleaves the amyloid precursor protein (APP) within the Abeta sequence and, therefore, precludes the formation of neurotoxic Abeta. To explore the correlation between the ADAM17 promoter and sporadic AD (SAD), a case-control study was conducted in a Northern Chinese Han population. The ADAM17 gene promoter region was screened, resulting in five known and one novel single nucleotide polymorphisms (SNP): -1672C/T (rs11689958), -1638T/G (rs1524668), -1437T/C (rs11684747), -1333C/T (rs12474969), -172T/C (rs12692386) and -154C/A. Using direct sequencing, genotypes were determined in 403 patients who had SAD and 323 control participants. No association was observed between these polymorphisms and SAD. These data indicated that, in a Northern Chinese Han population, SNP in the ADAM17 promoter do not influence the risk of SAD.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S S Sisodia
Aug 2, 1996·The Journal of Biological Chemistry·D J Selkoe
Jul 10, 2002·Neurology·J-C LambertM-C Chartier-Harlin
Nov 26, 2002·Biochemical and Biophysical Research Communications·Susan J TylerShelley J Allen
Jan 22, 2003·Biochemical and Biophysical Research Communications·Masashi AsaiShoichi Ishiura
Nov 5, 2003·Journal of Neuroscience Research·Tobias M J AllinsonNigel M Hooper
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Apr 9, 2008·Current Alzheimer Research·Rolf Postina

❮ Previous
Next ❯

Citations

Apr 15, 2014·Journal of Atherosclerosis and Thrombosis·You LiKe-Shen Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.